Evaluating the Effect of Aprepitant on Cyclophosphamide Pharmacokinetics.
Phase of Trial: Phase I
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Aprepitant (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Chemotherapy-induced nausea and vomiting; Early breast cancer
- Focus Pharmacogenomic; Pharmacokinetics
- Acronyms NRR
- 12 Aug 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History